http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2013142187-A
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-04 |
filingDate | 2012-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2015-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2013142187-A |
titleOfInvention | DERIVATIVES OF DIAMINOPYRIMIDINE AND METHODS FOR THEIR PRODUCTION |
abstract | 1. The use of a compound of formula 1 or a pharmaceutically acceptable salt thereof for the manufacture of a medicament for the prophylaxis or treatment of gastrointestinal motility dysfunction, characterized in using: Formula 1 wherein R represents a phenyl group substituted by one or more substituents selected from the group consisting of hydroxy, amino , halogen, cyano, nitro, hydroxycarbonyl, C1-6 alkyl (where C1-6alkyl is optionally substituted with halogen or amino), C1-6 alkenyl, C1-6 alkynyl, C1-4 alkoxy (where C1-4 alkoxy is optionally substituted m) C1-6alkylthio, mono- or di-C1-6alkylamino, C1-6alkylsulfonyl amino, C1-6alkylcarbonylamino, C1-6alkoxycarbonyl, aminosulfonyl, aminocarbonyl, C1-6alkylaminocarbonyl and benzyloxycarbonylamino; or a heteroaryl group selected from the group consisting of pyridinyl, pyrimidinyl, pyrazinyl, imidazolyl, pyrazolyl, triazolyl, oxazolyl, thiazolyl, furanyl, pyrrolyl, thiophenyl, naphthyl, indanyl, quinolinyl, quinolinonyl, di-dinonol-di-indolinol, , dihydrobenzimidazolonyl, benzoxazolonyl, benzofuranyl, benzothiophenyl, benzo [d] [1,3] dioxolyl, dihydrobenzo [1,4] dioxinyl, indolyl, indolinyl, benzimidazolyl, benzoxazolyl, benzothiazolyl and indazolyl, may be hetero eobyazatelno substituted with one or more substituents selected from the group consisting of amino, di-alkylamino, cyano, nitro, halogen, Ci ^ alkyl (wherein Ci ^ alkyl optionally substituted by halogen), alkoxy (wherein alkoxy optionally substituted with halogen), acetyl, and alkylsulfonyl, is hydrogen; An alkyl group optionally substituted with a substituent is selected |
priorityDate | 2011-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 863.